Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

Similar articles for PubMed (Select 11483633)

1.

A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.

Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM.

J Lipid Res. 2001 Aug;42(8):1308-17.

2.

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM.

J Lipid Res. 2000 Sep;41(9):1495-508.

3.

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M.

J Clin Invest. 1995 Dec;96(6):2882-91.

4.

Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.

Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1291-8.

5.

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM.

J Lipid Res. 2000 Sep;41(9):1481-94.

6.

Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells.

Reddy S, Hama S, Grijalva V, Hassan K, Mottahedeh R, Hough G, Wadleigh DJ, Navab M, Fogelman AM.

J Biol Chem. 2001 May 18;276(20):17030-5. Epub 2001 Mar 5.

7.

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.

Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA.

J Biol Chem. 1997 May 23;272(21):13597-607.

8.

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.

Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B.

Free Radic Biol Med. 1999 Apr;26(7-8):892-904.

PMID:
10232833
9.

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, Brennan ML, Lusis AJ, Fogelman AM, La Du BN.

J Clin Invest. 1997 Apr 15;99(8):2005-19. Erratum in: J Clin Invest 1997 Jun 15;99(12):3043.

10.

Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells.

Subbanagounder G, Deng Y, Borromeo C, Dooley AN, Berliner JA, Salomon RG.

Vascul Pharmacol. 2002 Apr;38(4):201-9.

PMID:
12449016
11.

Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.

Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2248-54.

12.

Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.

Mastorikou M, Mackness M, Mackness B.

Diabetes. 2006 Nov;55(11):3099-103.

13.

Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-alpha secretion by THP-1 human macrophages.

Girona J, La Ville AE, Heras M, Olivé S, Masana L.

Free Radic Biol Med. 1997;23(4):658-67.

PMID:
9215811
14.

PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity.

Yan D, Navab M, Bruce C, Fogelman AM, Jiang XC.

J Lipid Res. 2004 Oct;45(10):1852-8. Epub 2004 Jul 16.

15.

The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.

Staprans I, Pan XM, Rapp JH, Feingold KR.

Mol Nutr Food Res. 2005 Nov;49(11):1075-82. Review.

PMID:
16270280
16.

High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.

Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL, Watson AD, Lusis AJ, Berliner JA.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1346-53. Epub 2007 Mar 22.

17.
18.

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.

Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):481-8. Review. Erratum in: Arterioscler Thromb Vasc Biol 2001 May;21(5):880.

19.

The role of oxidized HDL in monocyte/macrophage functions in the pathogenesis of atherosclerosis in Rhesus monkeys.

Sharma N, Desigan B, Ghosh S, Sanyal SN, Ganguly NK, Majumdar S.

Scand J Clin Lab Invest. 1999 May;59(3):215-25.

PMID:
10400166
20.

Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine.

Ahmed Z, Babaei S, Maguire GF, Draganov D, Kuksis A, La Du BN, Connelly PW.

Cardiovasc Res. 2003 Jan;57(1):225-31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk